Podcasts > Archived Podcasts > Industry Focus
This show is no longer producing new episodes. Check out our other shows.
Industry Focus
Healthcare: Is It (Finally) OK To Buy Valeant and Gilead Sciences Again?
May 17, 2017 (23:44)
We dig into Valeant and Gilead Sciences' first quarter financials to see if shares are a bargain, or a bust.
Thanks to Slack for supporting The Motley Fool. Learn more at http://www.slack.com">slack.com.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.